antibodies abs solution Search Results


91
Alomone Labs ant 071
Ant 071, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ant 071/product/Alomone Labs
Average 91 stars, based on 1 article reviews
ant 071 - by Bioz Stars, 2026-02
91/100 stars
  Buy from Supplier

93
StressMarq nhe3
Nhe3, supplied by StressMarq, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nhe3/product/StressMarq
Average 93 stars, based on 1 article reviews
nhe3 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

94
Alomone Labs post ihc
Post Ihc, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/post ihc/product/Alomone Labs
Average 94 stars, based on 1 article reviews
post ihc - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

92
Boster Bio anti slc7a5
Anti Slc7a5, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti slc7a5/product/Boster Bio
Average 92 stars, based on 1 article reviews
anti slc7a5 - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier

90
ProSci Incorporated kidney
Kidney, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/kidney/product/ProSci Incorporated
Average 90 stars, based on 1 article reviews
kidney - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

93
Alomone Labs cystine glutamate antiporter
AhR activation status does not affect Nrf2 activation or transcriptional activity. RPTECs were cultured under ctrl conditions or subjected to Reox with or without the AhR inhibitor CH223191. (A) Representative western blots of Nrf2 levels (corresponding to its activation status) and the expression of the Nrf2 transcriptional targets xCT <t>(SLC7A11)</t> and SOD-3. (B-D) Statistical analysis of the western blots. Neither Reox nor CH223191 affects Nrf2 activity, or the expression of xCT and SOD-3. Data are presented as the mean ± SEM of six independent experiments. AhR, arylhydrocarbon receptor; Nrf2, nuclear factor erythroid 2-related factor 2; xCT, cystine-glutamate <t>antiporter;</t> SOD-3, superoxide dismutase; RPTEC, renal proximal tubular epithelial cell; ctrl, control; Reox, reoxygenation.
Cystine Glutamate Antiporter, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cystine glutamate antiporter/product/Alomone Labs
Average 93 stars, based on 1 article reviews
cystine glutamate antiporter - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

91
Alomone Labs experimental systems n
AhR activation status does not affect Nrf2 activation or transcriptional activity. RPTECs were cultured under ctrl conditions or subjected to Reox with or without the AhR inhibitor CH223191. (A) Representative western blots of Nrf2 levels (corresponding to its activation status) and the expression of the Nrf2 transcriptional targets xCT <t>(SLC7A11)</t> and SOD-3. (B-D) Statistical analysis of the western blots. Neither Reox nor CH223191 affects Nrf2 activity, or the expression of xCT and SOD-3. Data are presented as the mean ± SEM of six independent experiments. AhR, arylhydrocarbon receptor; Nrf2, nuclear factor erythroid 2-related factor 2; xCT, cystine-glutamate <t>antiporter;</t> SOD-3, superoxide dismutase; RPTEC, renal proximal tubular epithelial cell; ctrl, control; Reox, reoxygenation.
Experimental Systems N, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/experimental systems n/product/Alomone Labs
Average 91 stars, based on 1 article reviews
experimental systems n - by Bioz Stars, 2026-02
91/100 stars
  Buy from Supplier

93
Boster Bio slc10a1 ntcp rabbit boster
AhR activation status does not affect Nrf2 activation or transcriptional activity. RPTECs were cultured under ctrl conditions or subjected to Reox with or without the AhR inhibitor CH223191. (A) Representative western blots of Nrf2 levels (corresponding to its activation status) and the expression of the Nrf2 transcriptional targets xCT <t>(SLC7A11)</t> and SOD-3. (B-D) Statistical analysis of the western blots. Neither Reox nor CH223191 affects Nrf2 activity, or the expression of xCT and SOD-3. Data are presented as the mean ± SEM of six independent experiments. AhR, arylhydrocarbon receptor; Nrf2, nuclear factor erythroid 2-related factor 2; xCT, cystine-glutamate <t>antiporter;</t> SOD-3, superoxide dismutase; RPTEC, renal proximal tubular epithelial cell; ctrl, control; Reox, reoxygenation.
Slc10a1 Ntcp Rabbit Boster, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/slc10a1 ntcp rabbit boster/product/Boster Bio
Average 93 stars, based on 1 article reviews
slc10a1 ntcp rabbit boster - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

93
Boster Bio primary antibodies against slc20a1
AhR activation status does not affect Nrf2 activation or transcriptional activity. RPTECs were cultured under ctrl conditions or subjected to Reox with or without the AhR inhibitor CH223191. (A) Representative western blots of Nrf2 levels (corresponding to its activation status) and the expression of the Nrf2 transcriptional targets xCT <t>(SLC7A11)</t> and SOD-3. (B-D) Statistical analysis of the western blots. Neither Reox nor CH223191 affects Nrf2 activity, or the expression of xCT and SOD-3. Data are presented as the mean ± SEM of six independent experiments. AhR, arylhydrocarbon receptor; Nrf2, nuclear factor erythroid 2-related factor 2; xCT, cystine-glutamate <t>antiporter;</t> SOD-3, superoxide dismutase; RPTEC, renal proximal tubular epithelial cell; ctrl, control; Reox, reoxygenation.
Primary Antibodies Against Slc20a1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies against slc20a1/product/Boster Bio
Average 93 stars, based on 1 article reviews
primary antibodies against slc20a1 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

93
Boster Bio rabbit anti neun
AhR activation status does not affect Nrf2 activation or transcriptional activity. RPTECs were cultured under ctrl conditions or subjected to Reox with or without the AhR inhibitor CH223191. (A) Representative western blots of Nrf2 levels (corresponding to its activation status) and the expression of the Nrf2 transcriptional targets xCT <t>(SLC7A11)</t> and SOD-3. (B-D) Statistical analysis of the western blots. Neither Reox nor CH223191 affects Nrf2 activity, or the expression of xCT and SOD-3. Data are presented as the mean ± SEM of six independent experiments. AhR, arylhydrocarbon receptor; Nrf2, nuclear factor erythroid 2-related factor 2; xCT, cystine-glutamate <t>antiporter;</t> SOD-3, superoxide dismutase; RPTEC, renal proximal tubular epithelial cell; ctrl, control; Reox, reoxygenation.
Rabbit Anti Neun, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti neun/product/Boster Bio
Average 93 stars, based on 1 article reviews
rabbit anti neun - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

90
ProSci Incorporated goat anti boct
AhR activation status does not affect Nrf2 activation or transcriptional activity. RPTECs were cultured under ctrl conditions or subjected to Reox with or without the AhR inhibitor CH223191. (A) Representative western blots of Nrf2 levels (corresponding to its activation status) and the expression of the Nrf2 transcriptional targets xCT <t>(SLC7A11)</t> and SOD-3. (B-D) Statistical analysis of the western blots. Neither Reox nor CH223191 affects Nrf2 activity, or the expression of xCT and SOD-3. Data are presented as the mean ± SEM of six independent experiments. AhR, arylhydrocarbon receptor; Nrf2, nuclear factor erythroid 2-related factor 2; xCT, cystine-glutamate <t>antiporter;</t> SOD-3, superoxide dismutase; RPTEC, renal proximal tubular epithelial cell; ctrl, control; Reox, reoxygenation.
Goat Anti Boct, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/goat anti boct/product/ProSci Incorporated
Average 90 stars, based on 1 article reviews
goat anti boct - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

94
Alomone Labs separate window vacht
Primary Antibodies Used
Separate Window Vacht, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/separate window vacht/product/Alomone Labs
Average 94 stars, based on 1 article reviews
separate window vacht - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

Image Search Results


AhR activation status does not affect Nrf2 activation or transcriptional activity. RPTECs were cultured under ctrl conditions or subjected to Reox with or without the AhR inhibitor CH223191. (A) Representative western blots of Nrf2 levels (corresponding to its activation status) and the expression of the Nrf2 transcriptional targets xCT (SLC7A11) and SOD-3. (B-D) Statistical analysis of the western blots. Neither Reox nor CH223191 affects Nrf2 activity, or the expression of xCT and SOD-3. Data are presented as the mean ± SEM of six independent experiments. AhR, arylhydrocarbon receptor; Nrf2, nuclear factor erythroid 2-related factor 2; xCT, cystine-glutamate antiporter; SOD-3, superoxide dismutase; RPTEC, renal proximal tubular epithelial cell; ctrl, control; Reox, reoxygenation.

Journal: Molecular Medicine Reports

Article Title: Reoxygenation induces reactive oxygen species production and ferroptosis in renal tubular epithelial cells by activating aryl hydrocarbon receptor

doi: 10.3892/mmr.2020.11679

Figure Lengend Snippet: AhR activation status does not affect Nrf2 activation or transcriptional activity. RPTECs were cultured under ctrl conditions or subjected to Reox with or without the AhR inhibitor CH223191. (A) Representative western blots of Nrf2 levels (corresponding to its activation status) and the expression of the Nrf2 transcriptional targets xCT (SLC7A11) and SOD-3. (B-D) Statistical analysis of the western blots. Neither Reox nor CH223191 affects Nrf2 activity, or the expression of xCT and SOD-3. Data are presented as the mean ± SEM of six independent experiments. AhR, arylhydrocarbon receptor; Nrf2, nuclear factor erythroid 2-related factor 2; xCT, cystine-glutamate antiporter; SOD-3, superoxide dismutase; RPTEC, renal proximal tubular epithelial cell; ctrl, control; Reox, reoxygenation.

Article Snippet: Primary antibodies were specific for AhR (1:200; cat. no. sc-133088; Santa Cruz Biotechnology, Inc.), cytochrome P450 family 1 subfamily A member 1 (CYP1A1; 1:500; cat. no. sc-25304; Santa Cruz Biotechnology, Inc.), Nrf2 (1:1,000; cat. no. TA343586; OriGene Technologies, Inc.), superoxide dismutase 3 (SOD-3; 1:100; cat. no. sc-271170; Santa Cruz Biotechnology, Inc.), cystine-glutamate antiporter (xCT, also known as SLC7A11; 1:1,000; cat. no. ANT-111; Alomone Labs), HIF-1α (1:500; cat. no. sc-10790; Santa Cruz Biotechnology, Inc.), LDH-A (1:1,000; cat. no. 2012; Cell Signaling Technology, Inc.), activated cleaved caspase-3 (CC3; 1:1,000; cat. no. ab13847; Abcam) and β-actin (1:2,500; cat. no. 4967; Cell Signaling Technology, Inc.).

Techniques: Activation Assay, Activity Assay, Cell Culture, Western Blot, Expressing

Primary Antibodies Used

Journal: The Journal of comparative neurology

Article Title: Electron Microscopic Localization of M2-muscarinic receptors in Cholinergic and Non-Cholinergic Neurons of the Laterodorsal Tegmental and Pedunculopontine Nuclei of the Rat Mesopontine Tegmentum

doi: 10.1002/cne.24010

Figure Lengend Snippet: Primary Antibodies Used

Article Snippet: The immunolabeling was further shown to be specific for the antigenic VAchT peptide by absence of immunoreactivity in sections of brain tissue processed for immunolabeling after prior adsorption with cognate peptide but not with the carrier protein ( Arvidsson et al., 1997 ). table ft1 table-wrap mode="anchored" t5 caption a7 Antigen Immunogen Manufacturer Dilution M2R Synthetic fusion protein containing glutathione S-transferase fused to a part of the i3 intracellular loop of human M2R (residues 225-356) Alomone Labs Ltd (AMR-002 [lot AN-08]) RRID: AB_2039995Rabbit polyclonal 1:100 (gold) 1:2000 (peroxidase) VAchT 20 residue C-terminal synthetic peptide sequence corresponding to amino acids 511-530 of the cloned rat VAchT ImmunoStar (cat. 24286) RRID: AB_572269 Goat polyclonal 1:16000 (peroxidase) 1:3000 (gold) Open in a separate window VAchT, vesicular acetylcholine transporter; M2R, M2 muscarinic receptor. caption a8 Primary Antibodies Used The M2R immunoreactivity was detected with a rabbit polyclonal antiserum (product number AMR-002, Lot AN-08, RRID: AB_2039995, Alomone Labs Ltd, Jerusalem, Israel) ( ).

Techniques: Sequencing, Clone Assay

Neuronal distribution of  M2  and/or  VAchT  immunolabeled cellular profiles in the rat mesopontine PPT/LDT

Journal: The Journal of comparative neurology

Article Title: Electron Microscopic Localization of M2-muscarinic receptors in Cholinergic and Non-Cholinergic Neurons of the Laterodorsal Tegmental and Pedunculopontine Nuclei of the Rat Mesopontine Tegmentum

doi: 10.1002/cne.24010

Figure Lengend Snippet: Neuronal distribution of M2 and/or VAchT immunolabeled cellular profiles in the rat mesopontine PPT/LDT

Article Snippet: The immunolabeling was further shown to be specific for the antigenic VAchT peptide by absence of immunoreactivity in sections of brain tissue processed for immunolabeling after prior adsorption with cognate peptide but not with the carrier protein ( Arvidsson et al., 1997 ). table ft1 table-wrap mode="anchored" t5 caption a7 Antigen Immunogen Manufacturer Dilution M2R Synthetic fusion protein containing glutathione S-transferase fused to a part of the i3 intracellular loop of human M2R (residues 225-356) Alomone Labs Ltd (AMR-002 [lot AN-08]) RRID: AB_2039995Rabbit polyclonal 1:100 (gold) 1:2000 (peroxidase) VAchT 20 residue C-terminal synthetic peptide sequence corresponding to amino acids 511-530 of the cloned rat VAchT ImmunoStar (cat. 24286) RRID: AB_572269 Goat polyclonal 1:16000 (peroxidase) 1:3000 (gold) Open in a separate window VAchT, vesicular acetylcholine transporter; M2R, M2 muscarinic receptor. caption a8 Primary Antibodies Used The M2R immunoreactivity was detected with a rabbit polyclonal antiserum (product number AMR-002, Lot AN-08, RRID: AB_2039995, Alomone Labs Ltd, Jerusalem, Israel) ( ).

Techniques: Immunolabeling, Labeling

M2 immunolabeling in cholinergic and non-cholinergic neuronal cell bodies. A: A somatodendritic profile (M2-som) identified by Golgi complex cisterns (G) shows some gold particles for M2 (black straight arrows) associated to tubulovesicles (tv) or endoplasmic reticulum (RER) within the cytoplasm, or also attached to the plasma membrane. One M2-immunogold particle is also observed in a small unmyelinated axon in the near neuropil (M2-a). Dense immunoperoxidase precipitate por VAchT (white straight arrows) rims small synaptic vesicles (ssv) within a cholinergic axon terminal (VAchT-t). B: An M2-immunoreactive soma (M2-som) shows prominent M2-immunogold particles (black straight arrows) on membranes of tubulovesicles and on the plasma membrane. A dendrite (M2-d) showing prominent gold particles for M2 (black straight arrows) is seen in the adjoining neuropil, where two axon terminals (VAchT-t1,2) exhibit immunoperoxidase reaction product for VAchT. C: Intense VAchT-immunoperoxidase deposits (white straight arrows) are present on cisterns of the Golgi complex (G) and endomembranes within the cytoplasm in a soma (VAchT+M2-som) showing also M2-immunogold particles (black straight arrows) mainly on the plasma membrane. A M2-labeled dendrite (M2-d) showing immunogold particles for M2 (black straight arrows) is seen in the surrounding neuropil. D: A somatodendritic profile (VAchT+M2-som) showing major cytoplasmic distribution for M2-immunogold particles (black straight arrows) also displays more restricted dense VAchT-immunoperoxidase product (white straight arrows) mainly on Golgi cisterns or some adjacent endomembranes. Asterisks, glial profiles. Abbreviation: N, nucleus. Scale bar = 0.5 μm in A-D.

Journal: The Journal of comparative neurology

Article Title: Electron Microscopic Localization of M2-muscarinic receptors in Cholinergic and Non-Cholinergic Neurons of the Laterodorsal Tegmental and Pedunculopontine Nuclei of the Rat Mesopontine Tegmentum

doi: 10.1002/cne.24010

Figure Lengend Snippet: M2 immunolabeling in cholinergic and non-cholinergic neuronal cell bodies. A: A somatodendritic profile (M2-som) identified by Golgi complex cisterns (G) shows some gold particles for M2 (black straight arrows) associated to tubulovesicles (tv) or endoplasmic reticulum (RER) within the cytoplasm, or also attached to the plasma membrane. One M2-immunogold particle is also observed in a small unmyelinated axon in the near neuropil (M2-a). Dense immunoperoxidase precipitate por VAchT (white straight arrows) rims small synaptic vesicles (ssv) within a cholinergic axon terminal (VAchT-t). B: An M2-immunoreactive soma (M2-som) shows prominent M2-immunogold particles (black straight arrows) on membranes of tubulovesicles and on the plasma membrane. A dendrite (M2-d) showing prominent gold particles for M2 (black straight arrows) is seen in the adjoining neuropil, where two axon terminals (VAchT-t1,2) exhibit immunoperoxidase reaction product for VAchT. C: Intense VAchT-immunoperoxidase deposits (white straight arrows) are present on cisterns of the Golgi complex (G) and endomembranes within the cytoplasm in a soma (VAchT+M2-som) showing also M2-immunogold particles (black straight arrows) mainly on the plasma membrane. A M2-labeled dendrite (M2-d) showing immunogold particles for M2 (black straight arrows) is seen in the surrounding neuropil. D: A somatodendritic profile (VAchT+M2-som) showing major cytoplasmic distribution for M2-immunogold particles (black straight arrows) also displays more restricted dense VAchT-immunoperoxidase product (white straight arrows) mainly on Golgi cisterns or some adjacent endomembranes. Asterisks, glial profiles. Abbreviation: N, nucleus. Scale bar = 0.5 μm in A-D.

Article Snippet: The immunolabeling was further shown to be specific for the antigenic VAchT peptide by absence of immunoreactivity in sections of brain tissue processed for immunolabeling after prior adsorption with cognate peptide but not with the carrier protein ( Arvidsson et al., 1997 ). table ft1 table-wrap mode="anchored" t5 caption a7 Antigen Immunogen Manufacturer Dilution M2R Synthetic fusion protein containing glutathione S-transferase fused to a part of the i3 intracellular loop of human M2R (residues 225-356) Alomone Labs Ltd (AMR-002 [lot AN-08]) RRID: AB_2039995Rabbit polyclonal 1:100 (gold) 1:2000 (peroxidase) VAchT 20 residue C-terminal synthetic peptide sequence corresponding to amino acids 511-530 of the cloned rat VAchT ImmunoStar (cat. 24286) RRID: AB_572269 Goat polyclonal 1:16000 (peroxidase) 1:3000 (gold) Open in a separate window VAchT, vesicular acetylcholine transporter; M2R, M2 muscarinic receptor. caption a8 Primary Antibodies Used The M2R immunoreactivity was detected with a rabbit polyclonal antiserum (product number AMR-002, Lot AN-08, RRID: AB_2039995, Alomone Labs Ltd, Jerusalem, Israel) ( ).

Techniques: Immunolabeling, Labeling

Numbers of Asymmetric and Symmetric axodendritic synapses having  VAchT-  and/or  M2R-  immunoreactivity at pre- and/or post-synaptic sites within the rat mesopontine PPT and LDT nuclei.

Journal: The Journal of comparative neurology

Article Title: Electron Microscopic Localization of M2-muscarinic receptors in Cholinergic and Non-Cholinergic Neurons of the Laterodorsal Tegmental and Pedunculopontine Nuclei of the Rat Mesopontine Tegmentum

doi: 10.1002/cne.24010

Figure Lengend Snippet: Numbers of Asymmetric and Symmetric axodendritic synapses having VAchT- and/or M2R- immunoreactivity at pre- and/or post-synaptic sites within the rat mesopontine PPT and LDT nuclei.

Article Snippet: The immunolabeling was further shown to be specific for the antigenic VAchT peptide by absence of immunoreactivity in sections of brain tissue processed for immunolabeling after prior adsorption with cognate peptide but not with the carrier protein ( Arvidsson et al., 1997 ). table ft1 table-wrap mode="anchored" t5 caption a7 Antigen Immunogen Manufacturer Dilution M2R Synthetic fusion protein containing glutathione S-transferase fused to a part of the i3 intracellular loop of human M2R (residues 225-356) Alomone Labs Ltd (AMR-002 [lot AN-08]) RRID: AB_2039995Rabbit polyclonal 1:100 (gold) 1:2000 (peroxidase) VAchT 20 residue C-terminal synthetic peptide sequence corresponding to amino acids 511-530 of the cloned rat VAchT ImmunoStar (cat. 24286) RRID: AB_572269 Goat polyclonal 1:16000 (peroxidase) 1:3000 (gold) Open in a separate window VAchT, vesicular acetylcholine transporter; M2R, M2 muscarinic receptor. caption a8 Primary Antibodies Used The M2R immunoreactivity was detected with a rabbit polyclonal antiserum (product number AMR-002, Lot AN-08, RRID: AB_2039995, Alomone Labs Ltd, Jerusalem, Israel) ( ).

Techniques:

M2-immunoreactivity in dendrites without VAchT. A: Abundant M2-immunogold particles (black straight arrows) are nearly exclusively localized on the plasma membrane of a dendrite (M2-d) making a symmetric synapse (white curved arrow) with an unlabeled terminal (ut1) and appositional contacts (white arrowheads) with other unlabeled terminals (ut2,3). B: A transversely-sectioned large dendrite (M2-d1) exhibiting mainly cytoplasmic M2-immunogold particles (black straight arrows) receives multiple contacts from unlabeled terminals (ut1-3) whereas a small nearby dendrite (M2-d2) showing more obvious plasmalemmal M2-immunogold particles (black straight arrows) unveils no evident contact in the plane of section. Intense immunoperoxidase labeling for VAchT is seen in an adjoining axon terminal (VAchT-t). C: Prominent plasmalemmal localization of M2-immunogold particles (black straight arrows) in a dendrite (M2-d) that establishes an apparent symmetric contact (white curved arrow) with an axon terminal (M2-t) having also conspicuous plasmalemmal M2-immunogold (black straight arrows). The inset in the lower left corner shows an enlargement of the contact area illustrating localization of M2-immunogold particle to tubulovesicles attached to the postsynaptic membrane. VAchT-immunoperoxidase product is observed in some small cholinergic axons localized in the near immediacy (VAchT-a1) or more distant (VAchT-a2) to the M2-immunolabeled profiles. D: A longitudinally-sectioned dendrite (M2-d2) showing M2-immunogold (black straight arrows) in the cytoplasm forms extensive contact showing multiple synaptic junctions, most of them with unambiguous symmetric morphology (white curved arrow), with an axon terminal (M2-t) containing M2-immunogold particles, some of which are attached to the presynaptic side of the synapse. The M2-d2 also received a convergent asymmetric synapse (black curved arrow) from an unlabeled terminal (ut). M2-immunogold (black straight arrows) is also seen mainly associated to tubulovesicles (tv) within a nearby larger dendrite (M2-d1) contacting both M2-t and M2-d2. Scale bars = 0.5 μm in A-D.

Journal: The Journal of comparative neurology

Article Title: Electron Microscopic Localization of M2-muscarinic receptors in Cholinergic and Non-Cholinergic Neurons of the Laterodorsal Tegmental and Pedunculopontine Nuclei of the Rat Mesopontine Tegmentum

doi: 10.1002/cne.24010

Figure Lengend Snippet: M2-immunoreactivity in dendrites without VAchT. A: Abundant M2-immunogold particles (black straight arrows) are nearly exclusively localized on the plasma membrane of a dendrite (M2-d) making a symmetric synapse (white curved arrow) with an unlabeled terminal (ut1) and appositional contacts (white arrowheads) with other unlabeled terminals (ut2,3). B: A transversely-sectioned large dendrite (M2-d1) exhibiting mainly cytoplasmic M2-immunogold particles (black straight arrows) receives multiple contacts from unlabeled terminals (ut1-3) whereas a small nearby dendrite (M2-d2) showing more obvious plasmalemmal M2-immunogold particles (black straight arrows) unveils no evident contact in the plane of section. Intense immunoperoxidase labeling for VAchT is seen in an adjoining axon terminal (VAchT-t). C: Prominent plasmalemmal localization of M2-immunogold particles (black straight arrows) in a dendrite (M2-d) that establishes an apparent symmetric contact (white curved arrow) with an axon terminal (M2-t) having also conspicuous plasmalemmal M2-immunogold (black straight arrows). The inset in the lower left corner shows an enlargement of the contact area illustrating localization of M2-immunogold particle to tubulovesicles attached to the postsynaptic membrane. VAchT-immunoperoxidase product is observed in some small cholinergic axons localized in the near immediacy (VAchT-a1) or more distant (VAchT-a2) to the M2-immunolabeled profiles. D: A longitudinally-sectioned dendrite (M2-d2) showing M2-immunogold (black straight arrows) in the cytoplasm forms extensive contact showing multiple synaptic junctions, most of them with unambiguous symmetric morphology (white curved arrow), with an axon terminal (M2-t) containing M2-immunogold particles, some of which are attached to the presynaptic side of the synapse. The M2-d2 also received a convergent asymmetric synapse (black curved arrow) from an unlabeled terminal (ut). M2-immunogold (black straight arrows) is also seen mainly associated to tubulovesicles (tv) within a nearby larger dendrite (M2-d1) contacting both M2-t and M2-d2. Scale bars = 0.5 μm in A-D.

Article Snippet: The immunolabeling was further shown to be specific for the antigenic VAchT peptide by absence of immunoreactivity in sections of brain tissue processed for immunolabeling after prior adsorption with cognate peptide but not with the carrier protein ( Arvidsson et al., 1997 ). table ft1 table-wrap mode="anchored" t5 caption a7 Antigen Immunogen Manufacturer Dilution M2R Synthetic fusion protein containing glutathione S-transferase fused to a part of the i3 intracellular loop of human M2R (residues 225-356) Alomone Labs Ltd (AMR-002 [lot AN-08]) RRID: AB_2039995Rabbit polyclonal 1:100 (gold) 1:2000 (peroxidase) VAchT 20 residue C-terminal synthetic peptide sequence corresponding to amino acids 511-530 of the cloned rat VAchT ImmunoStar (cat. 24286) RRID: AB_572269 Goat polyclonal 1:16000 (peroxidase) 1:3000 (gold) Open in a separate window VAchT, vesicular acetylcholine transporter; M2R, M2 muscarinic receptor. caption a8 Primary Antibodies Used The M2R immunoreactivity was detected with a rabbit polyclonal antiserum (product number AMR-002, Lot AN-08, RRID: AB_2039995, Alomone Labs Ltd, Jerusalem, Israel) ( ).

Techniques: Labeling, Immunolabeling

Bar graph summarizing the mean±s.e. immunogold densities (number of gold particles per profile) in M2R-single and VAchT+M2R-dual large (>1μm) or small (<1μm) dendrites within the PPT/LDT. Mean densities were calculated based on the numbers obtained from 1345 VTA dendrites (407 large and 938 small) taken from ultrathin sections from 18 Vibratome sections in 4 rats (2874 total profiles) processed for dual labeling. *p<0.05, Fisher test for cytoplasmic versus plasmalemmal subcellular localization.

Journal: The Journal of comparative neurology

Article Title: Electron Microscopic Localization of M2-muscarinic receptors in Cholinergic and Non-Cholinergic Neurons of the Laterodorsal Tegmental and Pedunculopontine Nuclei of the Rat Mesopontine Tegmentum

doi: 10.1002/cne.24010

Figure Lengend Snippet: Bar graph summarizing the mean±s.e. immunogold densities (number of gold particles per profile) in M2R-single and VAchT+M2R-dual large (>1μm) or small (<1μm) dendrites within the PPT/LDT. Mean densities were calculated based on the numbers obtained from 1345 VTA dendrites (407 large and 938 small) taken from ultrathin sections from 18 Vibratome sections in 4 rats (2874 total profiles) processed for dual labeling. *p<0.05, Fisher test for cytoplasmic versus plasmalemmal subcellular localization.

Article Snippet: The immunolabeling was further shown to be specific for the antigenic VAchT peptide by absence of immunoreactivity in sections of brain tissue processed for immunolabeling after prior adsorption with cognate peptide but not with the carrier protein ( Arvidsson et al., 1997 ). table ft1 table-wrap mode="anchored" t5 caption a7 Antigen Immunogen Manufacturer Dilution M2R Synthetic fusion protein containing glutathione S-transferase fused to a part of the i3 intracellular loop of human M2R (residues 225-356) Alomone Labs Ltd (AMR-002 [lot AN-08]) RRID: AB_2039995Rabbit polyclonal 1:100 (gold) 1:2000 (peroxidase) VAchT 20 residue C-terminal synthetic peptide sequence corresponding to amino acids 511-530 of the cloned rat VAchT ImmunoStar (cat. 24286) RRID: AB_572269 Goat polyclonal 1:16000 (peroxidase) 1:3000 (gold) Open in a separate window VAchT, vesicular acetylcholine transporter; M2R, M2 muscarinic receptor. caption a8 Primary Antibodies Used The M2R immunoreactivity was detected with a rabbit polyclonal antiserum (product number AMR-002, Lot AN-08, RRID: AB_2039995, Alomone Labs Ltd, Jerusalem, Israel) ( ).

Techniques: Labeling

M2-immunolabeling in dendrites with VAchT. A: A dually labeled large dendrite (VAchT+M2-d) containing M2-immunogold particles (black straight arrows) mostly localized within the cytoplasm attached to vesicular endomembranes (tv) or to a multivesicular body (mvb) and VAchT-immunoperoxidase labeling (white straight arrows) also condensed especially to tv or mvb has large glial ensheathing (asterisks) but also receives input from unlabeled terminals (ut1,2), one of which is clearly asymmetric (black curved arrow). B: A dendrite (M2-d1) showing both VAchT-immunoperoxidase (white straight arrow) and M2-immunogold particles (black straight arrows) makes an asymmetric synapse (black curved arrow) with an unlabeled axon terminal (ut1) and a quite more symmetric synapse (white curved arrow) with another unlabeled axon terminal (ut2). Prominent plasmalemmal M2-immunogold particles (black straight arrows) are seen in a near dendrite (M2-d2) devoid of VAchT but receiving also input from unlabeled terminals (ut3,4). VAchT-immunoperoxidase is also detected in some small unmyelinated axons (VAchT-a1,2) in the surrounding area. C and D: Serial sections depicting a dual-labeled dendrite (VAchT+M2-d) showing both VAchT-immunoperoxidase (white straight arrows) and M2-immunogold particles (black straight arrows) receives an asymmetric synapse from an axon terminal lightly-labeled for VAchT (VAchT-t). The VAchT+M2-d is close to a longitudinally-sectioned M2-immunogold labeled dendrite (M2-d1), but intervening astrocytic leaflet keeps apart from apposition each other profile. Several M2-immugold particles (black straight arrows) are seen in some dendrites (M2-d2-4) in one and/or the other of the adjacent serial sections. Abbreviations: asterisks, glial processes. Scale bars = 0.5 μm in A-D.

Journal: The Journal of comparative neurology

Article Title: Electron Microscopic Localization of M2-muscarinic receptors in Cholinergic and Non-Cholinergic Neurons of the Laterodorsal Tegmental and Pedunculopontine Nuclei of the Rat Mesopontine Tegmentum

doi: 10.1002/cne.24010

Figure Lengend Snippet: M2-immunolabeling in dendrites with VAchT. A: A dually labeled large dendrite (VAchT+M2-d) containing M2-immunogold particles (black straight arrows) mostly localized within the cytoplasm attached to vesicular endomembranes (tv) or to a multivesicular body (mvb) and VAchT-immunoperoxidase labeling (white straight arrows) also condensed especially to tv or mvb has large glial ensheathing (asterisks) but also receives input from unlabeled terminals (ut1,2), one of which is clearly asymmetric (black curved arrow). B: A dendrite (M2-d1) showing both VAchT-immunoperoxidase (white straight arrow) and M2-immunogold particles (black straight arrows) makes an asymmetric synapse (black curved arrow) with an unlabeled axon terminal (ut1) and a quite more symmetric synapse (white curved arrow) with another unlabeled axon terminal (ut2). Prominent plasmalemmal M2-immunogold particles (black straight arrows) are seen in a near dendrite (M2-d2) devoid of VAchT but receiving also input from unlabeled terminals (ut3,4). VAchT-immunoperoxidase is also detected in some small unmyelinated axons (VAchT-a1,2) in the surrounding area. C and D: Serial sections depicting a dual-labeled dendrite (VAchT+M2-d) showing both VAchT-immunoperoxidase (white straight arrows) and M2-immunogold particles (black straight arrows) receives an asymmetric synapse from an axon terminal lightly-labeled for VAchT (VAchT-t). The VAchT+M2-d is close to a longitudinally-sectioned M2-immunogold labeled dendrite (M2-d1), but intervening astrocytic leaflet keeps apart from apposition each other profile. Several M2-immugold particles (black straight arrows) are seen in some dendrites (M2-d2-4) in one and/or the other of the adjacent serial sections. Abbreviations: asterisks, glial processes. Scale bars = 0.5 μm in A-D.

Article Snippet: The immunolabeling was further shown to be specific for the antigenic VAchT peptide by absence of immunoreactivity in sections of brain tissue processed for immunolabeling after prior adsorption with cognate peptide but not with the carrier protein ( Arvidsson et al., 1997 ). table ft1 table-wrap mode="anchored" t5 caption a7 Antigen Immunogen Manufacturer Dilution M2R Synthetic fusion protein containing glutathione S-transferase fused to a part of the i3 intracellular loop of human M2R (residues 225-356) Alomone Labs Ltd (AMR-002 [lot AN-08]) RRID: AB_2039995Rabbit polyclonal 1:100 (gold) 1:2000 (peroxidase) VAchT 20 residue C-terminal synthetic peptide sequence corresponding to amino acids 511-530 of the cloned rat VAchT ImmunoStar (cat. 24286) RRID: AB_572269 Goat polyclonal 1:16000 (peroxidase) 1:3000 (gold) Open in a separate window VAchT, vesicular acetylcholine transporter; M2R, M2 muscarinic receptor. caption a8 Primary Antibodies Used The M2R immunoreactivity was detected with a rabbit polyclonal antiserum (product number AMR-002, Lot AN-08, RRID: AB_2039995, Alomone Labs Ltd, Jerusalem, Israel) ( ).

Techniques: Immunolabeling, Labeling

VAchT-labeled terminals interactions with M2-labeled profiles. A: Immunoperoxidase reaction product for VAchT rims small synaptic vesicles within a terminal that establishes a symmetric synapse (white curved arrow) onto an M2-immunogold (black straight arrows) labeled dendrite (M2-d). B: A transversely-sectioned dendrite (M2-d) showing intracytoplasmic M2-immunogold particles receives convergent input from a VAchT-immunoperoxidase labeled terminal (VAchT-t) and an axon terminal (M2-t) containing numerous M2-immunogold particles. The appositional contact areas of M2-d with both axon terminals (VAchT-t and M2-t) are marked with white arrowheads. C: A small VAchT-immunoperoxidase labeled terminal (VAchT-t) contacts an astrocytic profile (M2-g1) containing two M2-immunogold particles (black straight arrows). The M2-g1 profile makes a gap junction with another glial astrocytic profile (M2-g2) that also partially contacts the VAcht-t and shows one M2-immunogold particle in the plane of section. D: Axon terminal (VAchT-t1) containing VAchT-immunoperoxidase product contacts another terminal (M2-t) showing plasmalemmal M2-immunogold particles (black straight arrows) that makes a symmetric synapse (white curved arrow) with a longitudinally-sectioned M2-labeled dendrite (M2-d). Two smaller intensely VAchT-labeled terminals (VAchT-t2,3) and a VAchT-labeled small unmyelinated axon (VAchT-a) are seen in the neighboring neuropil. terminal. Scale bars = 0.5 μm in A-D.

Journal: The Journal of comparative neurology

Article Title: Electron Microscopic Localization of M2-muscarinic receptors in Cholinergic and Non-Cholinergic Neurons of the Laterodorsal Tegmental and Pedunculopontine Nuclei of the Rat Mesopontine Tegmentum

doi: 10.1002/cne.24010

Figure Lengend Snippet: VAchT-labeled terminals interactions with M2-labeled profiles. A: Immunoperoxidase reaction product for VAchT rims small synaptic vesicles within a terminal that establishes a symmetric synapse (white curved arrow) onto an M2-immunogold (black straight arrows) labeled dendrite (M2-d). B: A transversely-sectioned dendrite (M2-d) showing intracytoplasmic M2-immunogold particles receives convergent input from a VAchT-immunoperoxidase labeled terminal (VAchT-t) and an axon terminal (M2-t) containing numerous M2-immunogold particles. The appositional contact areas of M2-d with both axon terminals (VAchT-t and M2-t) are marked with white arrowheads. C: A small VAchT-immunoperoxidase labeled terminal (VAchT-t) contacts an astrocytic profile (M2-g1) containing two M2-immunogold particles (black straight arrows). The M2-g1 profile makes a gap junction with another glial astrocytic profile (M2-g2) that also partially contacts the VAcht-t and shows one M2-immunogold particle in the plane of section. D: Axon terminal (VAchT-t1) containing VAchT-immunoperoxidase product contacts another terminal (M2-t) showing plasmalemmal M2-immunogold particles (black straight arrows) that makes a symmetric synapse (white curved arrow) with a longitudinally-sectioned M2-labeled dendrite (M2-d). Two smaller intensely VAchT-labeled terminals (VAchT-t2,3) and a VAchT-labeled small unmyelinated axon (VAchT-a) are seen in the neighboring neuropil. terminal. Scale bars = 0.5 μm in A-D.

Article Snippet: The immunolabeling was further shown to be specific for the antigenic VAchT peptide by absence of immunoreactivity in sections of brain tissue processed for immunolabeling after prior adsorption with cognate peptide but not with the carrier protein ( Arvidsson et al., 1997 ). table ft1 table-wrap mode="anchored" t5 caption a7 Antigen Immunogen Manufacturer Dilution M2R Synthetic fusion protein containing glutathione S-transferase fused to a part of the i3 intracellular loop of human M2R (residues 225-356) Alomone Labs Ltd (AMR-002 [lot AN-08]) RRID: AB_2039995Rabbit polyclonal 1:100 (gold) 1:2000 (peroxidase) VAchT 20 residue C-terminal synthetic peptide sequence corresponding to amino acids 511-530 of the cloned rat VAchT ImmunoStar (cat. 24286) RRID: AB_572269 Goat polyclonal 1:16000 (peroxidase) 1:3000 (gold) Open in a separate window VAchT, vesicular acetylcholine transporter; M2R, M2 muscarinic receptor. caption a8 Primary Antibodies Used The M2R immunoreactivity was detected with a rabbit polyclonal antiserum (product number AMR-002, Lot AN-08, RRID: AB_2039995, Alomone Labs Ltd, Jerusalem, Israel) ( ).

Techniques: Labeling

M2-immunolabeling in axon terminals with VAchT. A: Axon terminal containing VAchT-immunoperoxidase mainly on membranes of small synaptic vesicles (VAchT+M2-t) also shows M2-immunogold particles (black straight arrows) and apposes a large dendrite (M2-d) containing intracytoplasmic M2-immunogold. An adjacent axon terminal showing plasmalemmal M2-immunogold makes a symmetric contact (white straight arrow) with an unlabeled dendrite (ud) that receives convergent asymmetric input (black curved arrow) from an unlabeled terminal (ut). B: A dually labeled axon terminal (VAchT+M2-t) showing both VAchT-immunoperoxidase and plasmalemmal M2-immunogold particles (black straight arrows) makes a symmetric synapse onto an unlabeled dendrite (ud) receiving convergent asymmetric synaptic input from an unlabeled terminal (ut). A nearby dendrite (M2-d) shows also M2-immunogold labeling on the plasma membrane and tubulovesicular (tv) endomembranes. Scale bars = 0.5 μm in A-B.

Journal: The Journal of comparative neurology

Article Title: Electron Microscopic Localization of M2-muscarinic receptors in Cholinergic and Non-Cholinergic Neurons of the Laterodorsal Tegmental and Pedunculopontine Nuclei of the Rat Mesopontine Tegmentum

doi: 10.1002/cne.24010

Figure Lengend Snippet: M2-immunolabeling in axon terminals with VAchT. A: Axon terminal containing VAchT-immunoperoxidase mainly on membranes of small synaptic vesicles (VAchT+M2-t) also shows M2-immunogold particles (black straight arrows) and apposes a large dendrite (M2-d) containing intracytoplasmic M2-immunogold. An adjacent axon terminal showing plasmalemmal M2-immunogold makes a symmetric contact (white straight arrow) with an unlabeled dendrite (ud) that receives convergent asymmetric input (black curved arrow) from an unlabeled terminal (ut). B: A dually labeled axon terminal (VAchT+M2-t) showing both VAchT-immunoperoxidase and plasmalemmal M2-immunogold particles (black straight arrows) makes a symmetric synapse onto an unlabeled dendrite (ud) receiving convergent asymmetric synaptic input from an unlabeled terminal (ut). A nearby dendrite (M2-d) shows also M2-immunogold labeling on the plasma membrane and tubulovesicular (tv) endomembranes. Scale bars = 0.5 μm in A-B.

Article Snippet: The immunolabeling was further shown to be specific for the antigenic VAchT peptide by absence of immunoreactivity in sections of brain tissue processed for immunolabeling after prior adsorption with cognate peptide but not with the carrier protein ( Arvidsson et al., 1997 ). table ft1 table-wrap mode="anchored" t5 caption a7 Antigen Immunogen Manufacturer Dilution M2R Synthetic fusion protein containing glutathione S-transferase fused to a part of the i3 intracellular loop of human M2R (residues 225-356) Alomone Labs Ltd (AMR-002 [lot AN-08]) RRID: AB_2039995Rabbit polyclonal 1:100 (gold) 1:2000 (peroxidase) VAchT 20 residue C-terminal synthetic peptide sequence corresponding to amino acids 511-530 of the cloned rat VAchT ImmunoStar (cat. 24286) RRID: AB_572269 Goat polyclonal 1:16000 (peroxidase) 1:3000 (gold) Open in a separate window VAchT, vesicular acetylcholine transporter; M2R, M2 muscarinic receptor. caption a8 Primary Antibodies Used The M2R immunoreactivity was detected with a rabbit polyclonal antiserum (product number AMR-002, Lot AN-08, RRID: AB_2039995, Alomone Labs Ltd, Jerusalem, Israel) ( ).

Techniques: Immunolabeling, Labeling

Schematic diagram showing the primary distributions of M2 muscarinic receptors (M2Rs, stars) in neuronal profiles and glial profiles (g) that express (gray filling) or not (white filling) the vesicular acetylcholine transporter (VAchT, black circles) in the rat mesopontine PPT/LDT complex. The M2R is located in a non-VAchT soma (A) whose dendrites receive synaptic inputs from M2R-labeled, VAchT-labeled and/or unlabeled terminals. In these neurons and in VAchT-labeled neurons (B), the M2R is localized mainly to plasma membranes of dendrites, but is also associated with cytoplasmic membranes in both somata and dendrites. These dendrites receive many symmetric (inhibitory-type) and asymmetric (excitatory-type) synapses from terminals that do not contain either M2R or VAchT, both of which are separately located in nearby axonal and glial processes.

Journal: The Journal of comparative neurology

Article Title: Electron Microscopic Localization of M2-muscarinic receptors in Cholinergic and Non-Cholinergic Neurons of the Laterodorsal Tegmental and Pedunculopontine Nuclei of the Rat Mesopontine Tegmentum

doi: 10.1002/cne.24010

Figure Lengend Snippet: Schematic diagram showing the primary distributions of M2 muscarinic receptors (M2Rs, stars) in neuronal profiles and glial profiles (g) that express (gray filling) or not (white filling) the vesicular acetylcholine transporter (VAchT, black circles) in the rat mesopontine PPT/LDT complex. The M2R is located in a non-VAchT soma (A) whose dendrites receive synaptic inputs from M2R-labeled, VAchT-labeled and/or unlabeled terminals. In these neurons and in VAchT-labeled neurons (B), the M2R is localized mainly to plasma membranes of dendrites, but is also associated with cytoplasmic membranes in both somata and dendrites. These dendrites receive many symmetric (inhibitory-type) and asymmetric (excitatory-type) synapses from terminals that do not contain either M2R or VAchT, both of which are separately located in nearby axonal and glial processes.

Article Snippet: The immunolabeling was further shown to be specific for the antigenic VAchT peptide by absence of immunoreactivity in sections of brain tissue processed for immunolabeling after prior adsorption with cognate peptide but not with the carrier protein ( Arvidsson et al., 1997 ). table ft1 table-wrap mode="anchored" t5 caption a7 Antigen Immunogen Manufacturer Dilution M2R Synthetic fusion protein containing glutathione S-transferase fused to a part of the i3 intracellular loop of human M2R (residues 225-356) Alomone Labs Ltd (AMR-002 [lot AN-08]) RRID: AB_2039995Rabbit polyclonal 1:100 (gold) 1:2000 (peroxidase) VAchT 20 residue C-terminal synthetic peptide sequence corresponding to amino acids 511-530 of the cloned rat VAchT ImmunoStar (cat. 24286) RRID: AB_572269 Goat polyclonal 1:16000 (peroxidase) 1:3000 (gold) Open in a separate window VAchT, vesicular acetylcholine transporter; M2R, M2 muscarinic receptor. caption a8 Primary Antibodies Used The M2R immunoreactivity was detected with a rabbit polyclonal antiserum (product number AMR-002, Lot AN-08, RRID: AB_2039995, Alomone Labs Ltd, Jerusalem, Israel) ( ).

Techniques: Labeling